life expectancy with pulmonary hypertension

The life expectancy of individuals with pulmonary arterial hypertension (PAH) varies significantly due to individual differences. Generally, with timely diagnosis and appropriate treatment, patients can experience a marked improvement in both quality of life and survival. However, without intervention, the condition can progress rapidly, negatively impacting life expectancy.

PAH is a chronic and progressive disease that imposes an increased workload on the heart, potentially leading to heart failure. The expected lifespan of patients can vary widely, from a few years to over a decade, depending on the severity of the condition. Patients with mild PAH may enjoy a life expectancy comparable to that of the general population through medical treatment and lifestyle modifications. In contrast, those with moderate to severe PAH, despite advancements in modern medicine, may still face a significantly reduced life expectancy.

Early diagnosis, proactive treatment, and regular follow-ups are essential for individuals with PAH. Additionally, adhering to a healthy lifestyle as advised by their physicians, such as quitting smoking, limiting salt intake, and engaging in appropriate physical activity, is crucial for maximizing life expectancy and enhancing quality of life. Patients must strictly comply with their prescribed medication regimen, refraining from altering dosages or discontinuing medication without guidance, to ensure therapeutic efficacy. Any discomfort or concerns should be promptly addressed by seeking medical consultation.